Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.580-0.630 -0.0500
REV5.360M3.265M-2.095M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
MORF2.27%

Frequently Asked Questions

Q

How do I buy (MORF) stock?

A

You can purchase shares of (: MORF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are 's (MORF) competitors?

A

Other companies in ’s space includes: (:BLUE), (:ZNTL), (:FGEN), (:PRTA) and (:INO).

Q

What is the target price for (MORF) stock?

A

The latest price target for (: MORF) was reported by BMO Capital on May 3, 2021. The analyst firm set a price target for 102.00 expecting MORF to rise to within 12 months (a possible 57.43% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for (MORF)?

A

The stock price for (: MORF) is $64.79 last updated Wed Jun 16 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does (MORF) pay a dividend?

A

There are no upcoming dividends for .

Q

When is (:MORF) reporting earnings?

A
’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is (MORF) going to split?

A

There is no upcoming split for .

Q

What sector and industry does (MORF) operate in?

A

is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the .